It's a mixed bag of news for
Humana Inc. (HUM). While the company has been named amongst the '
Best Places to Work for People with Disabilities', it is also facing a class-action lawsuit from shareholders due to alleged securities fraud. Financial institutions are both buying and selling
Humana shares, pointing to a divided opinion on the companyβs prospects.
Appleseed Fund added
Humana during a dip while others like
Lord Abbett & CO. LLC and
Russell Investments Group Ltd. have sold large number of shares.
Humana has also collaborated with partners like PsychArmor to improve veteran care. However, disappointing Medicare Advantage growth and Medicare rates has shaken investor confidence. Additionally,
Humana has discontinued its
2025 profit forecast, citing increased medical costs which led to a stock tumble. Despite that, Wall Street seems to hold bullish views on the health insurance provider. Notably, there are also reports on the potential merger discussions with
Cigna, which ultimately fell through leading to a negative market reaction. Overall, the company appears to be mired in uncertainty, suggesting a rocky road ahead.
Humana HUM News Analytics from Wed, 15 Nov 2023 14:00:53 GMT to Sun, 21 Jul 2024 22:17:07 GMT -
Rating -1
- Innovation 4
- Information 6
- Rumor -8
